Annexin A2 plays a key role in protecting against cisplatin-induced AKI through β-catenin/TFEB pathway
Abstract Acute kidney injury (AKI) is in high prevalence in the world. However, the therapeutic strategies for AKI are still in mystery. Studies have shown to improve autophagy and lysosomal function could inhibit AKI. But their modulators need to be explored in detail. Annexin A2 (ANXA2) is a phosp...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-10-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-022-01224-w |